Canine ehrlichioses: an update.
The development of molecular biology techniques and methods for the isolation and growth of ehrlichias in tissue culture have greatly facilitated the study of these organisms. The available knowledge on ehrlichias is thus rapidly increasing and in this review recent findings on the epidemiology, transmission, clinical and laboratory signs of infection, diagnosis and treatment of canine ehrlichioses are described.
Kelly
P J
PJ
Biomedical Research and Training Institute, Harare, Zimbabwe.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001428:Bacterial Vaccines; D004283:Dog Diseases / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D004285:Dogs; D004536:Ehrlichia / Q000145:classification / Q000254:growth & development / Q000302:isolation & purification*; D016995:Ehrlichia ruminantium; D016873:Ehrlichiosis / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy / Q000662:veterinary*; D000077422:Enrofloxacin; D024841:Fluoroquinolones; D006801:Humans; D007095:Imidocarb / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015363:Quinolones / Q000627:therapeutic use; D013754:Tetracyclines
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; D024841:Fluoroquinolones; D015363:Quinolones; D013754:Tetracyclines; D000077422:Enrofloxacin; D007095:Imidocarb; C031719:imidocarb dipropionate